Universitätsklinikum Würzburg

Development of a simple and robust whole blood assay with dual co-stimulation to quantify the release of t-cellular signature cytokines in response to aspergillus fumigatus antigens (2021) Lauruschkat CD, Page L, White PL, Etter S, Davies HE, Duckers J, Ebel F, et al. Journal article TREATMENT TAPERING AND WITHDRAWAL IN RHEUMATOID ARTHRITIS WITH STABLE REMISSION - FINAL ANALYSIS OF THE RETRO STUDY (2021) Hagen M, Tascilar K, Reiser M, Valor L, Haschka J, Kleyer A, Hueber A, et al. Conference contribution LONG-TERM OUTCOME OF SSC ASSOCIATED ILD: IMPROVED SURVIVAL IN PPI TREATED PATIENTS (2021) Kreuter M, Bonella F, Kathrin K, Henes J, Siegert E, Riemekasten G, Blank N, et al. Conference contribution Re-Irradiation for Patients with Head and Neck Squamous Cell Carcinoma - A multicenter Analysis of 253 Patients of the jDEGRO Trial Group (2021) Roesch J, Oertel M, Dobiasch S, Fabian A, Fleischmann D, Von Der Gruen J, Hering D, et al. Conference contribution Tolerability of Tumor Treating Fields in pediatric high-grade glioma patients illustrated by post-market surveillance data (2021) Suchorska B, Lucaciu R, Jung S, Leyh J, Woelfl M, Hirt C, Scholz M Conference contribution Tumor Infiltrating Inflammatory Cells as a prognostic Factor in Glioblastoma (2021) Schnellhardt S, Zorob A, Polat B, Lisowski D, Daniel C, Monoranu CM, Fietkau R, Distel L Conference contribution Yoga effectively reduces fatigue and symptoms of depression in patients with different types of cancer (2021) Zetzl T, Renner A, Pittig A, Jentschke E, Roch C, Van Oorschot B Journal article CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to Aspergillus fumigatus (2021) Page L, Wallstabe J, Lother J, Bauser M, Kniemeyer O, Strobel L, Voltersen V, et al. Journal article Telemedicine in stroke-pertinent to stroke care in Germany (2021) Barlinn J, Winzer S, Worthmann H, Urbanek C, Haeusler KG, Guenther A, Erdur H, et al. Journal article Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study (2021) Kaehler KC, Gutzmer R, Meier F, Zimmer L, Heppt M, Gesierich A, Thoms KM, et al. Journal article